Cisplatin Injection IP 10 mg/10 ml

Cisplatin Injection IP 10 mg is a sterile oncology injectable formulation containing the platinum-based antineoplastic agent cisplatin. This product is intended strictly for export supply to licensed hospitals, oncology centers, and institutional healthcare facilities. Cisplatin is widely recognized in clinical oncology for its role in combination-based chemotherapy protocols across multiple solid tumor indications. AmeriDrugs supplies this product exclusively for B2B pharmaceutical procurement in regulated international markets.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Cisplatin IP

• Strength: 10 mg per 10 ml vial

• Formulation: Sterile aqueous solution

Therapeutic Use (Informational, Non-Advisory)
Cisplatin Injection IP 10 mg belongs to the class of platinum-containing antineoplastic agents. It is utilized in institutional oncology settings as part of established chemotherapy regimens for various malignancies, including but not limited to genitourinary, gastrointestinal, thoracic, and gynecological cancers. Therapeutic application depends on approved protocols and local regulatory guidance. No medical advice is provided.

Dosage Form & Route of Administration

• Dosage Form: Injectable solution

• Route of Administration: Intravenous infusion

• Prescription Status: Prescription-only medicine

• For hospital and institutional use only

Quality & Manufacturing Standards
Cisplatin Injection IP 10 mg is manufactured in compliance with applicable GMP standards. Production follows validated processes to ensure sterility, stability, and consistency. Quality control procedures include physicochemical testing, sterility assurance, and compliance with pharmacopeial specifications relevant to international export markets.

Packaging Information (Export-Oriented)

• Primary Packaging: Glass vial containing 10 ml sterile solution

• Secondary Packaging: Printed carton with regulatory labeling

• Packaging designed to support cold-chain and standard oncology supply logistics

• Export packaging customization available subject to importer requirements

Target Buyers

• Licensed pharmaceutical importers

• Oncology hospitals and cancer treatment centers

• Government and private institutional procurement agencies

• International distributors specializing in oncology injectables

Regulatory & Compliance Note
Cisplatin Injection IP 10 mg is a prescription-only oncology product intended strictly for professional use. Not for retail sale or direct consumer use. Product availability is subject to import regulations, local drug authority approvals, and institutional procurement policies in the destination country. AmeriDrugs adheres to global export compliance and documentation standards.